Raloxifene is mainly prescribed for the prevention and treatment of osteoporosis in postmenopausal women and for reducing the risk of invasive breast cancer. This intermediate has an important role in constructing the benzothiophene core structure that defines Raloxifene’s pharmacological activity. 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is a key intermediate compound employed to synthesize Raloxifene hydrochloride, a selective estrogen receptor modulator (SERM).
6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene
| API Name | Raloxifene |
|---|---|
| CAS No | 63675-74-1 |
| Molecular Formula | C16H14O2S |
| Molecular Weight | 270.3 g/mol |
| Synonyms | 6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Raloxifene is mainly prescribed for the prevention and treatment of osteoporosis in postmenopausal women and for reducing the risk of invasive breast cancer. This intermediate has an important role in constructing the benzothiophene core structure that defines Raloxifene’s pharmacological activity. 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is a key intermediate compound employed to synthesize Raloxifene hydrochloride, a selective estrogen receptor modulator (SERM).
The CAS number of 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is 63675-74-1.
The molecular formula of 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is C16H14O2S.
The listed molecular weight of 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is 270.3 g/mol.
6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is listed as being used in connection with the following API: Raloxifene.
The listed synonym or IUPAC name for 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene is 6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene.